A patient in China successfully underwent surgery to remove a painful grafted heart. The experiment was conducted by a team from the prestigious National Hospital for Transplant Recipients (NHTTR) in the city of Lanzhou.
The procedure was conducted on a 53-year-old man suffering from heart failure, which requires surgical injection. So far, no one has successfully succeeded in transplanting a new heart in these patients without surgery. The first outcome of this animal trial was achieved on a group of 20 patients in April 2018. Painlessly deteriorating condition of the afflicted man in June 2018 enabled this team to proceed with surgical procedure.
There was also a problem in dislocation of the heart due to prolonged use of a robotic ventilator and the failure to use bleeding control. Surgery was also necessary for medication.
Some experts reassured that this trial shows that medical procedures can be performed successfully and successfully on animals. For this reason, the team from NHTTR tried to perform organ harvesting with a mouse model and successfully succeeded in winning hearts with a tenfold cross section of organs.
From the second stage to the third stage, organ recovery was achieved in just five weeks. The team achieved this by surgically connecting a large section of abdominal epithelium and giving a super-human organ graft.
Human-to-human transplantation is a difficult task in the ultra-endowed organ transplantation field, but the system is highly promising in terms of the ethical and practical considerations. Furthermore, this animal-to-human and human-to-neoplasia-to-platelet transplantation also highlights how organ transplantation has an attractive and sustainable choice.